The global Eloctate market is estimated to grow at a significant CAGR during the forecast period. This drug is used to manage and prevent bleeding in people with hemophilia A, a hereditary medical condition that affects mostly men (low levels of factor VIII). It is frequently given to individuals with this disease before surgery to assist them to avoid severe bleeding. Factor VIII is a clotting factor found in normal blood that helps to form blood clots and halt bleeding after an injury. Low factor VIII levels can cause excessive bleeding after an injury or surgery, as well as internal bleeding (especially in the joints and muscles).

This medicine contains antihemophilic factor VIII (antihemophilic factor) that is connected to an antibody (immunoglobulin) that enables the factor VIII to present in the medicine to work for a longer time. When taken to control and prevent bleeding, this medication may assist to reduce the discomfort and long-term damage caused by hemophilia A. In the coming years, the global eloctate market will be driven by the increased rates of hemophilia. 

According to the Centers for Disease Control and Prevention, A affects 1 out of every 5,000 male births, while Hemophilia occurs in 1 out of 3000 male birth. In these circumstances, Eloctate that contains clotting factor VIII is utilized as the first line of treatment. As a result, the usage of Eloctate to treat Haemophilia A will propel the elocatate market forward. In November 2018, SOBI presented at the Jefferies Healthcare Conference 2018 in London. SOBI’s president and chief executive officer, Guido Oelkers, hailed the successful launch of its hemophilia products as one of its main growth drivers.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segments Covered

o By Type

o By Application

• Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

• Competitive Landscape: Sanofi

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Eloctate Market by Segments

By Type

• 200IU
• 250IU

By Application

• Hospital
• Pharmacy
• Other

Global Eloctate Market by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa